San Francisco-based private equity firm Genstar Capital LLC has completed its $797 milion acquisition of PRA International, a global clinical research organization based in North Carolina, the company announced today.

Shareholders approved the acquisition Wednesday and will receive $30.50 per share of common stock in cash. PRA stock will be delisted from Nasdaq at the close of the  markets.